Five things for pharma marketers to know: Tuesday, June 19, 2018

Share this content:

The Trump administration is expected to unveil a rule on Tuesday that would make it easier for businesses to offer health insurance plans exempt from many of the benefit requirements of the Affordable Care Act. Trade groups support the change, which could lower costs, but consumer groups and state officials argue it could remove healthy people from the ACA, driving up prices for older, sicker people. (New York Times)


CVS Health has partnered with the U.S. Postal Service on a home delivery service for prescription drugs, as it seeks to fend off threats from Amazon and startups such as PillPack. Customers will be charged $4.99 per delivery. (Wall Street Journal)


Roche has agreed to buy the percentage of Foundation Medicine that it does not already own for $2.4 billion. The acquisition, which would extend Roche's investment in personalized cancer care, is the latest in a string of buyouts by the Swiss drugmaker: earlier this year, it purchased of the rest of Flatiron Health for $1.9 billion. (Reuters)


Montefiore's Corazon - Give Your Heart campaign, a short film promoting organ donation, won the Health & Wellness Grand Prix in Cannes. (MM&M) Meanwhile, the Pharma jury declined to award a Grand Prix, marking the second year in a row the prize was not awarded in the category. “The statement we're making is that we need to enter more and have more ideas that do more than one thing well,” said Pharma jury president Rich Levy. (MM&M)


The FDA has rejected Valeant's application for Duobrii, its plaque psoriasis lotion. The lotion was touted by Valeant as one of its “significant seven,” a category of products it hopes could generate $1 billion in peak sales over the next four and a half years. Shares tumbled on the news. (Bloomberg)

Share this content:
Scroll down to see the next article